Page results
-
The Lysholm Department of Neuroradiology is a multidisciplinary team of healthcare professionals providing leading-edge neuroradiological services, performing around 60,000 examinations and procedures per year.
-
This page explains what you can expect during recovery from your CAR T-cell therapy.
-
UCLH is the only Supra-Centre in England to deliver Intracranial Stereotactic Radiosurgery and Stereotactic Radiotherapy Services (SRS/SRT) as part of an integrated neurosurgical and Neuro-oncology service to patients.
-
The department provides a unique and highly specialised clinical neuropsychological diagnostic and therapeutic service for in- and outpatients.
-
On 13 January 2020, a consultation which asks for people’s views on the future of planned orthopaedic surgery for adults in north central London was launched.
-
The clinical management of neuromuscular muscle wasting diseases such as motor neuron disease, myasthenia gravis, muscular dystrophy and peripheral neuropathy.
-
We are making it easier and safer for patients to be seen in an Emergency Department (ED) or Accident and Emergency (A&E) department without waiting for long periods of time.
-
Information about the council of governors at University College London Hospitals NHS Foundation Trust
-
Information about sickle cell disorder in adulthood for UCLH patients.
-
This is an easy read page for patients with deep vein thrombosis (DVT).
File results
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment
-
FOI/2022/0540 - Electronic patient record
-
FOI/2022/0541 - Serious Incidents Level 2 deaths/ serious harm
-
FOI/2022/0576 - Medications within dermatology